IN8bio director Alan Roemer resigns; Jeremy Graff appointed Interim Chair

IN8BIO, INC.

Alan S. Roemer resigned as director and from Audit and Compensation Committees, effective Feb 28, 2026.
Resignation not due to any disagreement with company, management, or board on operations, policies, or practices.
Board appointed Jeremy Graff, an independent director, as Interim Chair of the Board effective Feb 28, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.